Funded Grants

PI Name PI Organization Title Sort ascending Grant Number Initiative Program Official
Cohen, Lorenzo

University Of Tx Md Anderson Can Ctr
United States

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery 5R01CA272565-02 Brennan Streck, Ph.D., R.N., M.P.H.
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Doescher, Mark P

University Of Oklahoma Hlth Sciences Ctr
United States

Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub 1UG1CA287044-01 Elyse LeeVan, M.D., M.P.H.
Bae-Jump, Victoria Lin

Univ Of North Carolina Chapel Hill
United States

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer 5R37CA226969-07 Goli Samimi, Ph.D., M.P.H.
Cao, Yin

Washington University
United States

Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia 5R37CA246175-04 Asad Umar, D.V.M., Ph.D.
Giles, Erin

University Of Michigan At Ann Arbor
United States

Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause? 5R01CA269726-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.
Goldman, Radoslav

Georgetown University
United States

O-glycoproteins in the progression of liver disease 5R01CA238455-05 Matthew Young, Ph.D.
Goldman, Radoslav

Georgetown University
United States

O-glycoproteins in the progression of liver disease 5R01CA238455-05 Matthew Young, Ph.D.
Goldman, Radoslav

Georgetown University
United States

O-glycoproteins in the progression of liver disease 5R01CA238455-05 Matthew Young, Ph.D.
Goldman, Radoslav

Georgetown University
United States

O-glycoproteins in the progression of liver disease 5R01CA238455-05 Matthew Young, Ph.D.